Gastroenteropancreatic neuroendocrine neoplasm imaging: standard reporting templates
- PMID: 36201054
- DOI: 10.1007/s00261-022-03677-0
Gastroenteropancreatic neuroendocrine neoplasm imaging: standard reporting templates
Abstract
Purpose: Standardized reporting in radiology has an established role in numerous disease processes, with added benefits in oncology of reduced variability, and generation of a thorough and pertinent report with a focused and relevant conclusion. Many radiologists are not familiar with the imaging patterns of neuroendocrine neoplasm (NEN) spread and recurrence. This paper will present standardized CT, MRI, and PET templates for reporting gastroenteropancreatic (GEP) NENs and explain the rationale for including specific pertinent positive and negative findings, at various stages of disease management, based on site of origin.
Methods: Basic templates for initial and follow-up anatomic and molecular GEP NEN imaging were created with input from the multidisciplinary Society of Abdominal Radiology (SAR) Neuroendocrine Tumor Disease Focused Panel (NET-DFP). The templates were further modified and finalized after several iterations.
Results: Four main report templates were generated for (i) initial anatomic CT or MR imaging studies, (ii) follow-up anatomic CT or MR imaging studies, (iii) initial Somatostatin Receptor (SSTR) or FDG PET imaging studies, and (iv) follow-up SSTR or FDG PET imaging studies. Each study template was formatted to allow its integration into a dictation software directly and be modified as needed, with internalized instructions indicating where a drop-down menu or macro may be used to personalize the template as necessary.
Conclusion: These templates were created through a combination of multidisciplinary expert opinion discussion supported by literature review and provide basic structured reporting standards for GEP NEN anatomic and molecular imaging studies.
Keywords: Neuroendocrine Neoplasms; Pancreatic; Structured reporting; Template.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.Nucl Med Commun. 2016 Oct;37(10):1030-7. doi: 10.1097/MNM.0000000000000547. Nucl Med Commun. 2016. PMID: 27243215
-
Gastroenteropancreatic neuroendocrine tumours (GEP-NET) - Imaging and staging.Best Pract Res Clin Endocrinol Metab. 2016 Jan;30(1):45-57. doi: 10.1016/j.beem.2016.01.003. Epub 2016 Jan 20. Best Pract Res Clin Endocrinol Metab. 2016. PMID: 26971843 Review.
-
ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours.J Neuroendocrinol. 2022 Mar;34(3):e13044. doi: 10.1111/jne.13044. Epub 2021 Oct 25. J Neuroendocrinol. 2022. PMID: 34693574 Free PMC article. Review.
-
Diagnostic Management of Gastroenteropancreatic Neuroendocrine Neoplasms: Technique Optimization and Tips and Tricks for Radiologists.Tomography. 2023 Jan 27;9(1):217-246. doi: 10.3390/tomography9010018. Tomography. 2023. PMID: 36828370 Free PMC article. Review.
-
The Value of Somatostatin Receptor Scintigraphy (SRS) in Patients with NETG1/G2 Pancreatic Neuroendocrine Neoplasms (p-NENs).Nucl Med Rev Cent East Eur. 2019;22(1):1-7. doi: 10.5603/NMR.a2018.0032. Epub 2018 Oct 2. Nucl Med Rev Cent East Eur. 2019. PMID: 30276787
References
-
- Xu Z, Wang L, Dai S, Chen M, Li F, Sun J, et al. Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States. JAMA Network Open. 2021;4:e2124750–e2124750. doi: https://doi.org/10.1001/jamanetworkopen.2021.24750 - DOI - PubMed - PMC
-
- Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, et al. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. JAMA Oncol. 2017;3:1335–42. doi: https://doi.org/10.1001/jamaoncol.2017.0589 - DOI - PubMed - PMC
-
- Chan DL, Pavlakis N, Schembri GP, Bernard EJ, Hsiao E, Hayes A, et al. Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance. Theranostics. Ivyspring International Publisher; 2017;7:1149–58. doi: https://doi.org/10.7150/thno.18068 - DOI
-
- Brook OR, Brook A, Vollmer CM, Kent TS, Sanchez N, Pedrosa I. Structured reporting of multiphasic CT for pancreatic cancer: potential effect on staging and surgical planning. Radiology. United States; 2015;274:464–72. DOI: https://doi.org/10.1148/radiol.14140206 - DOI
-
- Dimarco M, Cannella R, Pellegrino S, Iadicola D, Tutino R, Allegra F, et al. Impact of structured report on the quality of preoperative CT staging of pancreatic ductal adenocarcinoma: assessment of intra- and inter-reader variability. Abdom Radiol (NY). United States; 2020;45:437–48. https://doi.org/10.1007/s00261-019-02287-7
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
